China’s First 2024 Biotech Acquisition by DCTY
DCTY's acquisition marks a milestone in China's biotech scene, introducing advanced TCR and CAR T-cell therapies domestically.
- Latest
- Trending
DCTY's acquisition marks a milestone in China's biotech scene, introducing advanced TCR and CAR T-cell therapies domestically.
Datadog reports strong Q2 revenue of $645M with 27% growth, adding 2,600 new customers and expanding product use.
Senior White House officials met with crypto leaders to discuss industry concerns but made no firm commitments.
Ottawa faces a $140M transit shortfall, risking tax hikes. Mayor urges federal and provincial aid for fairness.
The US Air Force is using AI drones for training, enhancing pilot readiness and introducing new warfare era.
Amid global market turmoil, the Fed holds firm on rates, focusing on employment and stability over market fluctuations.
Analysts cut Microchip Technology's earnings forecast by 71%, signaling potential challenges ahead for the tech firm.
YouTube's role as a freedom platform in Russia is at risk, with recent slowdowns heightening concerns over online expression.
Tri-Cities police test new tech to streamline mass evacuations, improving coordination and safety in emergencies.
Hanwha unveils its third US Innovation and Technology Center in Irvine, showcasing cutting-edge surveillance tech and analytics.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.